ARUN SREEKUMAR to Case-Control Studies
This is a "connection" page, showing publications ARUN SREEKUMAR has written about Case-Control Studies.
Connection Strength
0.126
-
Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer. J Natl Cancer Inst. 2004 Jun 02; 96(11):834-43.
Score: 0.035
-
Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival. Cancer. 2019 03 15; 125(6):921-932.
Score: 0.024
-
Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder. Eur Urol Focus. 2018 12; 4(6):907-915.
Score: 0.021
-
Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival. J Urol. 2016 06; 195(6):1911-9.
Score: 0.020
-
The role of sarcosine metabolism in prostate cancer progression. Neoplasia. 2013 May; 15(5):491-501.
Score: 0.016
-
Autoantibody signatures in prostate cancer. N Engl J Med. 2005 Sep 22; 353(12):1224-35.
Score: 0.010